Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leandra Piscopo

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cancers|July 14, 2023
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine NeoplasmsLeandra Piscopo, Emilia Zampella, Sara Pellegrino, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid CancerMichele Klain, Carmela Nappi, Marina De Risi, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 18, 2019
Identification and typing of cardiac amyloidosis by noninvasive imaging: Two cases for two patternsCarmela Nappi, Emilia Zampella, Fabio Volpe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2020
Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challengeMichele Klain, Carmela Nappi, Simone Maurea, et al.
Life (Basel, Switzerland)|September 23, 2022
Initial Testing of an Approximated, Fast Calculation Procedure for Personalized Dosimetry in Radionuclide Therapy Based on Planar Whole-Body Scan and Monte-Carlo Specific Dose Rates from the <i>OpenDose</i> ProjectDavide Bianco, Carmela Nappi, Leandra Piscopo, et al.
Cancers|August 26, 2023
Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score AnalysisLeandra Piscopo, Emilia Zampella, Fabio Volpe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 24, 2025
External validation of a predictive model for post-treatment persistent disease by <sup>131</sup>I whole-body scintigraphy in patients with differentiated thyroid cancerCarmela Nappi, Rosario Megna, Emilia Zampella, et al.
Endocrine|June 13, 2020
Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancerMichele Klain, Emilia Zampella, Mariarosaria Manganelli, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre StudyLeandra Piscopo, Fabio Volpe, Carmela Nappi, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center ExperienceLeandra Piscopo, Emilia Zampella, Fabio Volpe, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cancers|July 14, 2023
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine NeoplasmsLeandra Piscopo, Emilia Zampella, Sara Pellegrino, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid CancerMichele Klain, Carmela Nappi, Marina De Risi, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 18, 2019
Identification and typing of cardiac amyloidosis by noninvasive imaging: Two cases for two patternsCarmela Nappi, Emilia Zampella, Fabio Volpe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2020
Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challengeMichele Klain, Carmela Nappi, Simone Maurea, et al.
Life (Basel, Switzerland)|September 23, 2022
Initial Testing of an Approximated, Fast Calculation Procedure for Personalized Dosimetry in Radionuclide Therapy Based on Planar Whole-Body Scan and Monte-Carlo Specific Dose Rates from the <i>OpenDose</i> ProjectDavide Bianco, Carmela Nappi, Leandra Piscopo, et al.
Cancers|August 26, 2023
Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score AnalysisLeandra Piscopo, Emilia Zampella, Fabio Volpe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 24, 2025
External validation of a predictive model for post-treatment persistent disease by <sup>131</sup>I whole-body scintigraphy in patients with differentiated thyroid cancerCarmela Nappi, Rosario Megna, Emilia Zampella, et al.
Endocrine|June 13, 2020
Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancerMichele Klain, Emilia Zampella, Mariarosaria Manganelli, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre StudyLeandra Piscopo, Fabio Volpe, Carmela Nappi, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center ExperienceLeandra Piscopo, Emilia Zampella, Fabio Volpe, et al.
Pageof 4